Afficher la notice abrégée

dc.creatorStamati P., Siokas V., Aloizou A.-M., Karampinis E., Arseniou S., Rakitskii V.N., Tsatsakis A., Spandidos D.A., Gozes I., Mitsias P.D., Bogdanos D.P., Hadjigeorgiou G.M., Dardiotis E.en
dc.date.accessioned2023-01-31T10:01:58Z
dc.date.available2023-01-31T10:01:58Z
dc.date.issued2019
dc.identifier10.1007/s12031-019-01363-3
dc.identifier.issn08958696
dc.identifier.urihttp://hdl.handle.net/11615/79367
dc.description.abstractΑ number of genetic variants have been associated with Alzheimer’s disease (AD) susceptibility. Sec1 family domain-containing protein 1 (SCFD1) gene polymorphism rs10139154 has recently been implicated in the risk of developing amyotrophic lateral sclerosis (ALS). Similarities in the pathogenetic cascade of both diseases have also been described. The present study was designed to evaluate the possible contribution of SCFD1 rs10139154 to AD. A total of 327 patients with AD and an equal number of healthy controls were included in the study and genotyped for rs10139154. With logistic regression analyses, rs10139154 was examined for the association with the risk of developing AD. In the recessive mode, SCFD1 rs10139154 was associated with a decreased risk of developing AD (odds ratio (OR) (95% confidence interval (CI)) = 0.63 (0.40–0.97), p = 0.036). The current study provides preliminary evidence of the involvement of SCFD1 rs10139154 in the risk of developing AD. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.en
dc.language.isoenen
dc.sourceJournal of Molecular Neuroscienceen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85068779862&doi=10.1007%2fs12031-019-01363-3&partnerID=40&md5=3b41e913e2d3923aa3296b75d08fa3ee
dc.subjectmembrane proteinen
dc.subjectSec1 family domain containing protein 1en
dc.subjectunclassified drugen
dc.subjectSly1 protein, humanen
dc.subjectvesicular transport adaptor proteinen
dc.subjectageden
dc.subjectAlzheimer diseaseen
dc.subjectArticleen
dc.subjectcontrolled studyen
dc.subjectfemaleen
dc.subjectgene frequencyen
dc.subjectgenetic associationen
dc.subjectgenetic risken
dc.subjectgenotypeen
dc.subjecthumanen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectsingle nucleotide polymorphismen
dc.subjectAlzheimer diseaseen
dc.subjectgeneticsen
dc.subjectvery elderlyen
dc.subjectAdaptor Proteins, Vesicular Transporten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAlzheimer Diseaseen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectPolymorphism, Single Nucleotideen
dc.subjectSpringer New York LLCen
dc.titleDoes SCFD1 rs10139154 Polymorphism Decrease Alzheimer’s Disease Risk?en
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée